Skip to main content
News

Systemic Pulse Steroid Therapy Rapidly Stabilizes Vitiligo but Shows Limited Long-Term Disease Control

A single-center retrospective study suggests that intravenous steroid pulse (IVSP) therapy can rapidly stabilize active vitiligo, although maintaining long-term disease control remains challenging, particularly in patients with high baseline disease burden. Given the lack of consensus on systemic corticosteroid regimens, this study aimed to evaluate the efficacy and safety of systemic pulse therapy in patients with progressive generalized vitiligo. 

Researchers reviewed medical records of 19 patients treated with IVSP between 2021 and 2023. Patients were categorized into 2 groups based on response: a stable group (n=6) and a progressive/refractory group (n=13). Disease severity and response were assessed using the Vitiligo Extent Score (VES) at baseline and immediately after treatment.

Short-term outcomes demonstrated strong disease stabilization: 94.7% of patients achieved stable disease immediately following treatment, indicating effective suppression of active autoimmune melanocyte destruction. However, repigmentation was limited, with only marginal decreases in VES scores across both groups.

Long-term outcomes revealed a clear divergence between patient subgroups. While the stable group maintained disease control, most patients in the progressive/refractory group experienced relapse or continued progression during follow up. Two key factors associated with poorer long-term outcomes were identified: acral involvement and higher baseline disease severity.

“IVSP is a potent tool for the rapid induction of stability in active vitiligo, but its ability to maintain long-term remission is limited,” the authors concluded. “While the treatment yields high immediate satisfaction in stable cohorts, the high relapse rate in the progressive cohort underscores the need for a multi-modality treatment.”

These findings support IVSP as an effective short-term strategy for halting disease progression, while highlighting the need for combination approaches, such as phototherapy or targeted systemic therapies, to sustain long-term remission.

Reference

Fang WC, Lan CCE. Efficacy and safety of systemic pulse therapy in vitiligo: a single center retrospective study. Presented at: American Academy of Dermatology Annual Meeting; March 27–31, 2026; Denver, Colorado.

© 2026 HMP Global. All Rights Reserved.
Any views and opinions expressed are those of the author(s) and/or participants and do not necessarily reflect the views, policy, or position of the Dermatology Learning Network or HMP Global, their employees, and affiliates.